Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Withdrawn study sought to identify cancer patients safe for home care during fever

NCT ID NCT04557709

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 27 times

Summary

This study was designed to look at cancer patients with neutropenic fever (a serious side effect of chemotherapy) who might be eligible for a 'hospital at home' program, where they receive acute care at home instead of in the hospital. Researchers planned to review medical charts to see how many patients had major complications and what factors made home care risky. However, the study was withdrawn before enrolling any participants, so no results are available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID NEOPLASM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.